Oncotelic Therapeutics, Inc. Retained Earnings
Oncotelic Therapeutics, Inc. (OTLC) had Retained Earnings of $209.43 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) $209.43M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $209.05M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $211.24M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$39.11M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | $209.43M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $209.05M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $211.24M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$39.11M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | -$38.06M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$38.34M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$38.04M 10-K · filed 2026-04-15 | |
| 2024-09-30 | -$37.44M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | -$34.14M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$33.93M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$33.52M 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$32.78M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$32.90M 10-Q · filed 2023-08-18 | |
| 2023-03-31 | -$26.14M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | -$25.93M 10-K · filed 2024-04-12 | |
| 2022-09-30 | -$20.64M 10-Q · filed 2022-11-18 | |
| 2022-06-30 | -$19.86M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | -$35.87M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | -$31.02M 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | -$29.23M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | -$27.66M 10-Q · filed 2021-08-20 | |
| 2021-03-31 | -$24.43M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | -$21.63M 10-K · filed 2022-04-15 | |
| 2020-09-30 | -$18.19M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$16.20M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$16.79M 10-Q · filed 2020-06-29 | |
| 2019-12-31 | -$12.13M 10-K · filed 2021-04-15 | |
| 2019-09-30 | -$8.65M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | -$7.65M 10-Q · filed 2019-08-19 | |
| 2019-03-31 | -$295.64M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$5.49M 10-K · filed 2020-05-14 | -$295.01M 10-K · filed 2019-04-10 |
| 2018-09-30 | -$294.39M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$293.71M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$293.07M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | -$292.27M 10-K · filed 2019-04-10 | |
| 2017-09-30 | -$289.84M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$286.31M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | -$282.42M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$278.46M 10-K · filed 2018-04-17 | |
| 2016-09-30 | -$275.01M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$271.77M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | -$268.13M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | -$264.81M 10-K · filed 2017-03-30 | |
| 2015-09-30 | -$260.84M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$257.25M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$253.93M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$251.16M 10-K · filed 2016-03-25 | |
| 2014-09-30 | -$248.52M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$245.07M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | -$241.14M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$238.51M 10-K · filed 2015-03-30 | |
| 2013-09-30 | -$236.41M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$231.45M 10-Q/A · filed 2013-10-18 | -$228.97M 10-Q · filed 2013-08-12 |
| 2013-03-31 | -$227.31M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$225.43M 10-K · filed 2014-03-20 | |
| 2012-09-30 | -$223.76M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$221.51M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | -$219.24M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$217.35M 10-K · filed 2013-03-15 | |
| 2011-09-30 | -$215.01M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | -$211.50M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | -$207.70M 10-K · filed 2012-03-28 |